Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

MEK162 for Patients With RAS/RAF/MEK Activated Tumors

ClinicalTrials.gov ID: NCT01885195

Public ClinicalTrials.gov record NCT01885195. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 6:29 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Modular Phase II Study to Link Targeted Therapy to Patients With Pathway Activated Tumors: Module 3 - MEK162 for Patients With RAS/RAF/MEK Activated Tumors

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this signal seeking study is to determine whether treatment with MEK162 demonstrates sufficient efficacy in select pathway-activated solid tumors and/or hematologic malignancies to warrant further study

Study identification

NCT ID
NCT01885195
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
110 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 10, 2013 (Actual)
Primary completion
Oct 1, 2015 (Actual)
Completion
Apr 11, 2017 (Actual)
Last update posted
Feb 21, 2021

2013 – 2017

United States locations

U.S. sites
68
U.S. states
32
U.S. cities
60
Facility City State ZIP Site status
University of South Alabama / Mitchell Cancer Institute Univ South Alabama Mobile Alabama 36688 —
Alaska Oncology and Hematology AOH (2) Anchorage Alaska 99508 —
Arizona Oncology Associates AZ Oncology Assoc. Phoenix Arizona — —
Arizona Oncology Associates HOPE Division Phoenix Arizona — —
Arizona Oncology Associates PC- NAHOA Sedona Arizona 86336 —
Highlands Oncology Group Highlands Oncology Group (22) Fayetteville Arkansas 72703 —
PCR Oncology Pismo Beach California 93449 —
University of California Davis Cancer Center UC Davis Cancer (3) Sacramento California 95817 —
Rocky Mountain Cancer Centers USOR Boulder Colorado 80304 —
Yale University School of Medicine Yale Cancer Center New Haven Connecticut 06511 —
Whittingham Cancer Center Norwalk Hospital Norwalk Connecticut 06856 —
Eastern Connecticut Hematology & Oncology Associates Dept. of ECHO Norwich Connecticut 06360 —
Hematology Oncology PC Stamford Hospital Stamford Connecticut 06902 —
Florida Cancer Specialists Florida Cancer Specialists (31 Fort Myers Florida 33901 —
Memorial Cancer Institute Memorial Healthcare System Hollywood Florida 33021 —
Cancer Specialists of North Florida Jacksonville Florida 32256 —
Mt. Sinai Comprehensive Cancer Center Miami Beach Florida 33140 —
Ocala Oncology Center Dept. of Ocala Oncology Center Ocala Florida 34474 —
Cancer Centers of Florida PA Cancer Centers of FL-Orlando-4 Ocoee Florida — —
University Cancer & Blood Center, LLC Athens Georgia 30607 —
Lurie Children's Hospital of Chicago Developmental Therapeutics Chicago Illinois 60611 —
Oncology Specialists, SC Onc Specialists Park Ridge Illinois 60068-0736 —
Illinois Cancer Care IL. Cancer Care Peoria Illinois 61615-7828 —
Indiana University Indiana Univ. - Purdue Univ. Indianapolis Indiana 46202 —
University of Iowa Hospitals & Clinics Regulatory Contact 2 Iowa City Iowa 52242 —
Maryland Oncology Hematology, P.A. Oncology Hematology Rockville Maryland 20850 —
Cancer and Hematology Centers of West Michigan Dept. of Oncology Grand Rapids Michigan 49546 —
Metro MN CCOP - Coon Rapids Coon Rapids Minnesota 55433 —
Research Medical Center Research Med Center (2) Kansas City Missouri 64132 —
Washington University School of Medicine Washington University (16) St Louis Missouri 63110 —
Glacier View Research Institute - Cancer Oncology Dept Kalispell Montana 59901 —
Comprehensive Cancer Centers of Nevada CCC of Nevada (21) Las Vegas Nevada 89109 —
Cancer Institute of New Jersey CINJ New Brunswick New Jersey 08901 —
New Mexico Cancer Care Alliance Oncology Dept Albuquerque New Mexico 87106 —
New York Oncology Hematology, P.C. NYOH Latham Troy New York 12180 —
University of North Carolina Chapel Hill Physician Office Building Chapel Hill North Carolina 27514 —
Duke University Medical Center Seeley G. Mudd Bldg. Durham North Carolina 27710 —
Sanford Research/USD-Fargo Sanford Hematology Oncology Fargo North Dakota 58122 —
Cleveland Clinic Foundation Cleveland Clinic (19) Cleveland Ohio 44195 —
Ohio State University Medical Center Comprehensive Cancer Center Columbus Ohio 43221 —
St. Charles Cancer Center Bend Oregon 97701 —
Willamette Valley Clinical Studies Cancer Institute & Res. Ctr. Eugene Oregon 97404 —
Northwest Cancer Specialists Vancouver Cancer Center Portland Oregon 97210 —
Oregon Health & Science University Oregon Health & Science U (56) Portland Oregon 97239 —
St. Luke's Hospital and Health Network St Luke's (2) Bethlehem Pennsylvania — —
West Penn Allegheny Oncology Network Natrona Heights Pennsylvania 15065 —
Abington Hematology Oncology Associates, Inc Abington Hem Onc Assoc (5) Willow Grove Pennsylvania 19090 —
Chattanooga Oncology and Hematology Assoicates, PC Chattanooga Oncology Chattanooga Tennessee 37404 —
The West Clinic Dept. of the West Clinic Memphis Tennessee 38120 —
Sarah Cannon Research Institute Sarah Cannon Research Inst (51 Nashville Tennessee 37203 —
Texas Oncology Presbyterian Hospital (3) Dallas Texas 75246 —
Texas Oncology Texas Oncology - Denton Dallas Texas 75246 —
Texas Oncology Austin Midtown Dallas Texas 75251 —
Texas Oncology Texas Oncology - Midland Dallas Texas 75251 —
Sammons Cancer Center - Texas Oncology Sammons Cancer Center (10) Dallas Texas 78246 —
Oncology Consultants Oncology Group Houston Texas 77024 —
MD Anderson Cancer Center/University of Texas MD Anderson Cancer Center (3) Houston Texas 77030 —
Cancer Care Centers of South Texas / HOAST CCC of So. TX-San Antonio (3) San Antonio Texas 78229 —
Tyler Cancer Center Dept.ofTylerCancerCtr. (2) Tyler Texas 75702 —
Deke Slayton Cancer Center Deke Slayton Cancer Center (2) Webster Texas 77598 —
Intermountain Medical Center Intermountain Healthcare Murray Utah 84157 —
Virginia Cancer Specialists, PC Virginia Cancer Specialists Fairfax Virginia 22031 —
Medical Oncology & Hematology Associates of Northern VA Med Onc Hem Northern VA Reston Virginia 20190 —
Kadlec Clinic Hematology and Oncology Kadlec Clinic Hematology & Onc Kennewick Washington 99336 —
Providence Regional Cancer System Lacey Washington 98503 —
MultiCare Health System Institute for Research & Innovation MultiCare Tacoma Washington 98405 —
Northwest Medical Specialties NW Medical Specialties Tacoma Washington 98405 —
Medical College of Wisconsin Cancer Center Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01885195, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 21, 2021 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01885195 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →